1. Home
  2. IRWD
  3. IRWD News

Latest Ironwood Pharmaceuticals Inc. (IRWD) News on April 2, 2025

IRWD

MT Newswires

5 days ago

Ironwood Pharmaceuticals Gets Nasdaq Non-Compliance Notice

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
IRWD

Business Wire

5 days ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
IRWD

Zacks

7 days ago

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?
IRWD

Insider Monkey

a month ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
IRWD

Zacks

a month ago

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ...
IRWD

GuruFocus.com

a month ago

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ...

IRWD

Thomson Reuters StreetEvents

a month ago

Q4 2024 Ironwood Pharmaceuticals Inc Earnings Call

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates
IRWD

Zacks

a month ago

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates

IRWD

Associated Press Finance

a month ago

Ironwood: Q4 Earnings Snapshot

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
IRWD

Business Wire

a month ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For
IRWD

GuruFocus.com

a month ago

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
IRWD

Business Wire

a month ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Millrose Properties Set to Join S&P SmallCap 600
IRWD

PR Newswire

2 months ago

Millrose Properties Set to Join S&P SmallCap 600

IRWD

Argus Research

2 months ago

IRWD: Lowering target price to $2.00

IRWD

MT Newswires

2 months ago

Top Midday Decliners

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls
IRWD

Zacks

2 months ago

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls

IRWD

MT Newswires

2 months ago

Ironwood Pharmaceuticals to Slash Half of Workforce, Drop Phase 2 Testing of Drug; Issues 2025 Outlook

IRWD

Business Wire

2 months ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

IRWD

Argus Research

2 months ago

IRWD: What does Argus have to say about IRWD?

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
IRWD

Simply Wall St.

2 months ago

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

IRWD

Argus Research

2 months ago

IRWD: What does Argus have to say about IRWD?

0246810AI: Slightly Negative
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
IRWD

TipRanks

2 months ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

IRWD

Argus Research

3 months ago

IRWD: Lowering target price to $3.00

IRWD

Argus Research

3 months ago

IRWD: Raising target price to $4.00

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)
IRWD

Insider Monkey

3 months ago

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)

IRWD

Argus Research

3 months ago

IRWD: What does Argus have to say about IRWD?

0246810AI: Negative
IRWD

Argus Research

4 months ago

IRWD: What does Argus have to say about IRWD?

High Growth Tech Stocks In The United States To Watch
IRWD

Simply Wall St.

4 months ago

High Growth Tech Stocks In The United States To Watch

IRWD

Argus Research

4 months ago

IRWD: What does Argus have to say about IRWD?

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
IRWD

Business Wire

4 months ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
IRWD

Business Wire

5 months ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

IRWD

Argus Research

5 months ago

IRWD: What does Argus have to say about IRWD?

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
IRWD

Zacks

5 months ago

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...
IRWD

GuruFocus.com

5 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
IRWD

Zacks

5 months ago

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates

IRWD

Associated Press Finance

5 months ago

Ironwood: Q3 Earnings Snapshot

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
IRWD

Business Wire

5 months ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect
IRWD

GuruFocus.com

5 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect

IRWD

Argus Research

5 months ago

IRWD: Raising target price to $4.00

IRWD

MT Newswires

5 months ago

Ironwood Says Apraglutide Shows 'Consistent Treatment Effect' in Short Bowel Syndrome; Shares Rise

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
IRWD

Business Wire

5 months ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
IRWD

Business Wire

5 months ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares
IRWD

GuruFocus.com

6 months ago

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares

0246810AI: Positive
Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?
IRWD

Insider Monkey

6 months ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...
IRWD

GuruFocus.com

6 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...

0246810AI: Positive
IRWD

Argus Research

6 months ago

IRWD: What does Argus have to say about IRWD?

0246810AI: Negative
Implied Volatility Surging for Ironwood (IRWD) Stock Options
IRWD

Zacks

7 months ago

Implied Volatility Surging for Ironwood (IRWD) Stock Options

0246810AI: Positive
IRWD

MT Newswires

7 months ago

Leerink Partners Initiates Coverage on Ironwood Pharmaceuticals With Market Perform Rating, $5 Price Target

Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?
IRWD

Insider Monkey

7 months ago

Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
IRWD

Business Wire

7 months ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

0246810AI: Highly Positive
IRWD

Argus Research

7 months ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

7 months ago

IRWD: Raising target price to $4.00

Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13%
IRWD

Simply Wall St.

8 months ago

Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13%

0246810AI: Negative
Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
IRWD

Simply Wall St.

8 months ago

Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

0246810AI: Neutral
Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
IRWD

Zacks

8 months ago

Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates

0246810AI: Negative
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
IRWD

Zacks

8 months ago

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2

0246810AI: Neutral
IRWD

Associated Press Finance

8 months ago

Ironwood: Q2 Earnings Snapshot

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
IRWD

Business Wire

8 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline
IRWD

Zacks

8 months ago

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline

0246810AI: Neutral
Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders have endured a 49% loss from investing in the stock three years ago
IRWD

Simply Wall St.

8 months ago

Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders have endured a 49% loss from investing in the stock three years ago

0246810AI: Negative
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
IRWD

Business Wire

8 months ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

0246810AI: Neutral
IRWD

Argus Research

8 months ago

IRWD: Lowering target price to $5.00

0246810AI: Slightly Negative
Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options
IRWD

Zacks

9 months ago

Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options

0246810AI: Neutral
IRWD

Argus Research

9 months ago

IRWD: Raising target price to $6.00

0246810AI: Slightly Negative
IRWD

Argus Research

9 months ago

IRWD: What does Argus have to say about IRWD?

0246810AI: Neutral
IRWD

Argus Research

9 months ago

IRWD: Lowering target price to $5.00

0246810AI: Negative
IRWD

MT Newswires

9 months ago

Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer

Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
IRWD

GuruFocus.com

10 months ago

Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)

0246810AI: Slightly Positive
Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...
IRWD

GuruFocus.com

10 months ago

Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...

IRWD

MT Newswires

10 months ago

Ironwood Pharmaceuticals Insider Sold Shares Worth $517,694, According to a Recent SEC Filing

0246810AI: Neutral
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
IRWD

Business Wire

10 months ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

0246810AI: Slightly Negative
IRWD

MT Newswires

10 months ago

Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
IRWD

Business Wire

10 months ago

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

0246810AI: Highly Positive
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
IRWD

Simply Wall St.

a year ago

US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results

IRWD

GuruFocus.com

a year ago

Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements

0246810AI: Slightly Negative
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
IRWD

Insider Monkey

a year ago

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript

0246810AI: Slightly Negative
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
IRWD

Zacks

a year ago

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates

0246810AI: Negative
Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)
IRWD

Simply Wall St.

a year ago

Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)

0246810AI: Neutral
IRWD

MT Newswires

a year ago

Sector Update: Health Care Stocks Higher Late Afternoon

0246810AI: Highly Positive
IRWD

MT Newswires

a year ago

Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading

IRWD

MT Newswires

a year ago

Sector Update: Health Care

0246810AI: Positive
IRWD

MT Newswires

a year ago

Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut

IRWD

Associated Press Finance

a year ago

Ironwood: Q1 Earnings Snapshot

Ironwood Pharmaceuticals Reports First Quarter 2024 Results
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals Reports First Quarter 2024 Results

0246810AI: Highly Positive
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference

0246810AI: Neutral
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
IRWD

Newsfile

a year ago

Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
IRWD

Zacks

a year ago

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

0246810AI: Highly Positive
IRWD

Argus Research

a year ago

IRWD: Raising target price to $9.00

0246810AI: Highly Positive
Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)

0246810AI: Highly Positive
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
IRWD

Zacks

a year ago

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2

It’s Time! 3 Failing Biotech Stocks to Sell Right Now
IRWD

InvestorPlace

a year ago

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All
IRWD

Investor's Business Daily

a year ago

Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All

IRWD

Reuters

a year ago

UPDATE 1-Ironwood's bowel disease treatment meets main goal in late-stage trial

IRWD

Reuters

a year ago

Ironwood says bowel disease treatment meets main goal in late-stage trial

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference

Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
IRWD

Simply Wall St.

a year ago

Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
IRWD

Insider Monkey

a year ago

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use